Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
US10052314B2 · kind B2 · utility
7Cited by
71References
25Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 21, 2017 |
| Grant date | Aug 21, 2018 |
| Priority date | — |
| Expiry date | Dec 21, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are methods of treating non-metastatic castrate-resistant prostate cancer with anti-androgens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.